Drug Donanemab Offers New Hope in Dementia Fight

A new drug, Donanemab, is being hailed as a turning point in the fight against Alzheimer’s, after a global trial confirms it slows cognitive decline. The antibody medicine helps in the early stages of the disease by clearing a protein that builds up in the brains of people with this type of dementia. Although not a cure, charities say the results in the journal JAMA mark a new era where Alzheimer’s can be treated.

Read More

See for Yourself

Meet Erica Lathrop, Sales Director!

The Cordwainer | Erica Lathrop

I understand the first step is the hardest. Schedule a tour today and experience my personalized approach to showing families how we’re redefining memory care on the South Shore.

Please enable JavaScript in your browser to complete this form.